Letters discuss social media trends in drug promotion, highlighting regulatory and methodological issues.
To the Editor A recent research letter provides evidence on high-engagement social media posts pertaining to pharmaceutical promotion.1 While the analysis addressed an important regulatory concern, several methodological issues may affect the interpretation of the study’s findings.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: